BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 23238187)

  • 1. The prevalence of Rhesus negativity among pregnant women in Enugu, Southeast Nigeria.
    Okeke TC; Ocheni S; Nwagha UI; Ibegbulam OG
    Niger J Clin Pract; 2012; 15(4):400-2. PubMed ID: 23238187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pregnant Rhesus negative Nigerian woman.
    Kotila TR; Odukogbe AA; Okunlola MA; Olayemi O; Obisesan KA
    Niger Postgrad Med J; 2005 Dec; 12(4):305-7. PubMed ID: 16380744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The importance of laboratory diagnosis in allo-immunization through pregnancy and hemolytic disease of the newborn].
    Florea DP
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):211-3. PubMed ID: 20509304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhesus alloimmunization in pregnancy. A tertiary care center experience in the Western region of Saudi Arabia.
    Bondagji NS
    Saudi Med J; 2011 Oct; 32(10):1039-45. PubMed ID: 22008924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
    Katsulov A
    Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
    [No Abstract]   [Full Text] [Related]  

  • 7. Economics of anti-rhesus prophylaxis in an African population.
    Verkuyl DA
    Cent Afr J Med; 1987 Feb; 33(2):32-7. PubMed ID: 3121186
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    VÅ­lcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of Rh negative pregnant women who attended the antenatal clinic and delivered in Rajavithi Hospital: 2000-2005.
    Puangsricharern A; Suksawat S
    J Med Assoc Thai; 2007 Aug; 90(8):1491-4. PubMed ID: 17926974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical aspects of prenatal prevention of rhesus incompatibility].
    Maas DH
    Beitr Infusionsther; 1992; 30():425-30. PubMed ID: 1284752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
    Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
    Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B; Mugyenyi G; Brand A; Schonewille H
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of the clinical utility of routine antenatal screening of pregnant women at first clinic attendance for haemoglobin genotypes, haematocrit, ABO and Rh blood groups in Port Harcourt, Nigeria.
    Jeremiah ZA
    Afr J Reprod Health; 2005 Dec; 9(3):112-7. PubMed ID: 16623195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S; Eliezer E; Piper I; Woliovitch I
    J Matern Fetal Neonatal Med; 2003 Dec; 14(6):404-6. PubMed ID: 15061320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing hemolytic disease of the newborn.
    Brantley TA
    Clin Lab Sci; 2002; 15(3):140-3. PubMed ID: 12778961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.